UVA Scientists Unlock Early Treatment Path for NF1 Tumors

Researchers at UVA have discovered how tumors begin in patients with neurofibromatosis Type 1, opening doors to treatments that could stop tumors before they start. The breakthrough reveals how surrounding cells influence tumor growth, potentially changing how doctors treat this painful genetic condition.